Abstract :
Peripheral arterial disease (PAD) is a progressive atherosclerotic condition that may involve multilevel arterial segments and often coexists with aneurysmal disease. We report the case of a 78-year-old male with extensive cardiovascular comorbidities who underwent staged multilevel endovascular revascularization of the tibial and femoropopliteal segments for severe PAD with concomitant aneurysmal disease. Following abnormal vascular imaging during preoperative cardiac clearance, he underwent right tibial and tibioperoneal trunk angioplasty followed by left femoral-popliteal aneurysm repair and stenting. Postoperative recovery was uneventful apart from transient acute kidney injury. This case illustrates the diagnostic and therapeutic challenges of complex PAD, highlights the evolving role of multilevel endovascular interventions, and contextualizes decision-making with current evidence and guidelines.
Keywords :
Aneurysmal disease, Angioplasty, Endovascular revascularization, Multilevel intervention, Peripheral arterial disease, StentingReferences :
1. Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–1340.
2. Crawford JD, Perrone KH, Wong VW, et al. A modern series of popliteal artery aneurysms: repair and outcomes. J Vasc Surg. 2014;59(1):77–83.
3. Conte MS, Bradbury AW, Kolh P, et al. Global Vascular Guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):S3–S125.e40.
4. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67.
5. Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83(6):E212–E220.
6. Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease. J Am Coll Cardiol. 2017;69(11):e71–e126.
7. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509–1526.
8. Farber A, Menard MT. Endovascular intervention for peripheral artery disease. Circ Res. 2021;128(12):1882–1902.
9. Zeller T, Baumgartner I, Scheinert D, et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results. Circulation. 2014;129(9):926–933.
10. Dake MD, Ansel GM, Jaff MR, et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation. 2016;133(15):1472–1483.
11. Armstrong EJ, Anderson DR, Yeo KK, et al. Endovascular intervention for critical limb ischemia. Circ Cardiovasc Interv. 2014;7(5):646–653.
12. Katsanos K, Spiliopoulos S, Kitrou P, et al. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery: a systematic review and meta-analysis. JAMA. 2018;319(23):2373–2383.
13. Bradbury AW, Adam DJ, Bell J, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–1934.
14. Farber A, Menard MT, Conte MS, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387:2305–2316.
15. Zeller T, Rastan A, Macharzina R, et al. Drug-eluting balloons for treatment of femoropopliteal lesions: 24-month results from the randomized LEVANT 2 trial. J Am Coll Cardiol. 2014;64(15):1561–1570.
16. Bosiers M, Deloose K, Callaert J, et al. Supera stent outcomes in the superficial femoral and proximal popliteal artery in the real world: 12-month results from the SUPERB trial. J Endovasc Ther. 2015;22(6):701–707.
